Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Leinonen

Showing results (261-270 of 268) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 268 results.
Molecular Therapy. Methods & Clinical Development|April 30, 2020
Development of Large-Scale Downstream Processing for Lentiviral VectorsAnniina J Valkama, Igor Oruetxebarria, Eevi M Lipponen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2009
Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trialH Joensuu, L Sailas, T Alanko, et al.
Molecular Therapy. Methods & Clinical Development|October 26, 2019
Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent CellsHanna M Leinonen, Eevi M Lipponen, Anniina J Valkama, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 3, 2011
Very high quantitative tumor HER2 content and outcome in early breast cancerH Joensuu, J Sperinde, M Leinonen, et al.
Scandinavian Journal of Infectious Diseases|July 22, 1998
Aetiology of acute epiglottitis in adultsB Trollfors, O Nylén, C Carenfelt, et al.
Cancer Research|October 9, 2012
Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatmentHanna M Leinonen, Anna-Kaisa Ruotsalainen, Ann-Marie Määttä, et al.
Frontiers in Medicine|March 20, 2023
Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapyReetta A E Eriksson, Tiina Nieminen, Lionel Galibert, et al.
Oncogene|August 25, 2019
Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastomaPetri Pölönen, Ashik Jawahar Deen, Hanna M Leinonen, et al.
Pageof 27

Showing results (261-270 of 268) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 268 results.
Molecular Therapy. Methods & Clinical Development|April 30, 2020
Development of Large-Scale Downstream Processing for Lentiviral VectorsAnniina J Valkama, Igor Oruetxebarria, Eevi M Lipponen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2009
Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trialH Joensuu, L Sailas, T Alanko, et al.
Molecular Therapy. Methods & Clinical Development|October 26, 2019
Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent CellsHanna M Leinonen, Eevi M Lipponen, Anniina J Valkama, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 3, 2011
Very high quantitative tumor HER2 content and outcome in early breast cancerH Joensuu, J Sperinde, M Leinonen, et al.
Scandinavian Journal of Infectious Diseases|July 22, 1998
Aetiology of acute epiglottitis in adultsB Trollfors, O Nylén, C Carenfelt, et al.
Cancer Research|October 9, 2012
Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatmentHanna M Leinonen, Anna-Kaisa Ruotsalainen, Ann-Marie Määttä, et al.
Frontiers in Medicine|March 20, 2023
Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapyReetta A E Eriksson, Tiina Nieminen, Lionel Galibert, et al.
Oncogene|August 25, 2019
Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastomaPetri Pölönen, Ashik Jawahar Deen, Hanna M Leinonen, et al.
Pageof 27